Jade Biosciences, Inc.
Jade Biosciences, Inc. (JBIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
jbio · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$55.00
Consensus
$44.20
+195.1% upside
Low
$34.00
Median: $45 · Last Close: $14.98
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$44.20
195.1% upside
High Target
$55
267.2%
Low Target
$34
127.0%
Current Price
$14.98
as of today
Based on analyst price targets, the JBIO stock price prediction for the next 12 months ranges from $34 to $55. The consensus JBIO price forecast of $44.20 implies 195.1% upside from the current price of $14.98.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $14.23 | ↓ 5.00% |
1-day model range: $13.87–$14.59. Peak: $14.59 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | +35.2% |
| 2028 | — | +61.5% |
| 2029 | — | +78.7% |
| 2030 | — | +89.2% |
| 2031 | — | +95.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · JBIO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-01 | BTIG | Maintains | Buy→Buy |
| 2026-05-27 | BTIG | Maintains | Buy→Buy |
| 2026-05-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-11 | Guggenheim | Maintains | Buy→Buy |
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-16 | BTIG | Maintains | Buy→Buy |
| 2026-03-11 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Jade Biosciences, Inc. (JBIO) stock. Of the recent 15 rating actions, 1 were upgrades and 0 were downgrades. 4 analysts currently cover JBIO.
Analyst Recommendation Trends
JBIO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-2.66
EPS Next Year
$-2.65
↓ 0.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast JBIO EPS of $-2.66 for the current fiscal year, based on estimates from 7 analysts. The JBIO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The JBIO stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus JBIO price target is $44.20 (+195.1% upside), with an analyst consensus of Buy.
The JBIO short-term stock prediction for tomorrow is $14.23 (-5.00%). The JBIO stock prediction for 2030 projects a range of $25–$31.
Jade Biosciences, Inc. trades on NASDAQ under the ticker JBIO. The JBIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
JBIO forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month JBIO price target is $44.20, with a high forecast of $55.00 and a low of $34.00. The median price target is shown in the chart above when available. This implies +195.1% potential upside from the current price of $14.98.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.